Ziac (Teva Women’s Health, Inc.)
Welcome to the PulseAid listing for the Ziac drug offered from Teva Women’s Health, Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Women’s Health, Inc. |
NON-PROPRIETARY NAME: | bisoprolol fumarate and hydrochlorothiazide |
SUBSTANCE NAME: | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1993-10-26 |
END MARKETING DATE: | 0000-00-00 |
Ziac HUMAN PRESCRIPTION DRUG Details:
Item Description | Ziac from Teva Women’s Health, Inc. |
LABELER NAME: | Teva Women’s Health, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10; 6.25(mg/1; mg/1) |
START MARKETING DATE: | 1993-10-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51285-040_29f71ed0-65d0-4d39-a8e7-e400a4913ab0 |
PRODUCT NDC: | 51285-040 |
APPLICATION NUMBER: | NDA020186 |
Other BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers: